live attenuated varicella vaccine (Varivax) Report issue

Vaccine Approved FDA
AACT
Back

Drug Pricing Summary

VA Big4

$94.8560 - $155.6050

VA FSS

$129.9520 - $209.0750

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
varicella-zoster virus strain oka/merck live antigen 1350 [PFU] / 0.5 mL (0.5 mL INJECTION) $94.8560 VA Big4
  • VARIVAX (10)
    		•  Merck Sharp & Dohme Corporation
    varicella-zoster virus strain oka/merck live antigen 1350 [PFU] / 0.5 mL (0.5 mL INJECTION) $129.9520 VA FSS
  • VARIVAX (10)
    		•  Merck Sharp & Dohme Corporation
    varicella-zoster virus strain oka/merck live antigen 19400 [PFU] / 0.65 mL (0.7 mL INJECTION) $105.9565 VA Big4
  • ZOSTAVAX (1.5)
    		•  Merck Sharp & Dohme Corporation
    varicella-zoster virus strain oka/merck live antigen 19400 [PFU] / 0.65 mL (0.7 mL INJECTION) $142.5840 VA FSS
  • ZOSTAVAX (1.5)
    		•  Merck Sharp & Dohme Corporation
    varicella-zoster virus strain oka/merck live antigen 19400 [PFU] / 0.65 mL (0.7 mL INJECTION) $155.6050 VA Big4
  • ZOSTAVAX (10)
    		•  Merck Sharp & Dohme Corporation
    varicella-zoster virus strain oka/merck live antigen 19400 [PFU] / 0.65 mL (0.7 mL INJECTION) $209.0750 VA FSS
  • ZOSTAVAX (10)
    		•  Merck Sharp & Dohme Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue